<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04281667</url>
  </required_header>
  <id_info>
    <org_study_id>14112018</org_study_id>
    <nct_id>NCT04281667</nct_id>
  </id_info>
  <brief_title>Mechanical Bowel Preparation and Oral Antibiotics Versus Mechanical Bowel Preparation Only Prior Rectal Surgery</brief_title>
  <acronym>MOBILE2</acronym>
  <official_title>Mechanical Bowel Preparation and Oral Antibiotics Versus Mechanical Bowel Preparation Only Prior Rectal Surgery - a Prospective, Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Helsinki University Central Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      MOBILE2 is a randomized controlled trial comparing mechanical and oral antibiotic bowel
      preparation to mechanical bowel preparation only in patients undergoing anterior rectal
      resection with primary anastomosis. Primary endpoint is Comprehensive Complication Index
      within 30 days from surgery.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2020</start_date>
  <completion_date type="Anticipated">March 2027</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comprehensive Complication Index</measure>
    <time_frame>Within 30 days from surgery</time_frame>
    <description>Comprehensive Complication Index score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Surgical Site Infection</measure>
    <time_frame>Within 30 days from surgery</time_frame>
    <description>Surgical site infection as defined by CDC</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anastomotic dehiscence</measure>
    <time_frame>Within 30 days from surgery</time_frame>
    <description>Anastomotic dehiscence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lenght of hospital stay</measure>
    <time_frame>Within hospital stay, estimated on average 7 days</time_frame>
    <description>Lenght of hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>Within 90 days from surgery</time_frame>
    <description>Mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adjuvant therapy</measure>
    <time_frame>Within 6 months from surgery</time_frame>
    <description>Patients receiving adjuvant therapy divided by patients needing adjuvant therapy</description>
  </secondary_outcome>
  <other_outcome>
    <measure>5-year overall survival</measure>
    <time_frame>5 years from surgery</time_frame>
    <description>5-year overall survival</description>
  </other_outcome>
  <other_outcome>
    <measure>5-year disease specific survival</measure>
    <time_frame>5 years from surgery</time_frame>
    <description>5-year disease specific survival</description>
  </other_outcome>
  <other_outcome>
    <measure>5-year recurrence free survival</measure>
    <time_frame>5 years from surgery</time_frame>
    <description>5-year recurrence free survival</description>
  </other_outcome>
  <other_outcome>
    <measure>Quality of life (SF-36)</measure>
    <time_frame>At randomization and at one year from surgery</time_frame>
    <description>Difference in quality of life between baseline and 1 year measured using SF-36</description>
  </other_outcome>
  <other_outcome>
    <measure>Quality of life (QLQ-C30)</measure>
    <time_frame>At randomization and at one year from surgery</time_frame>
    <description>Difference in quality of life between baseline and 1 year measured using QLQ-C30</description>
  </other_outcome>
  <other_outcome>
    <measure>Quality of life (QLQ-CR29)</measure>
    <time_frame>At randomization and at one year from surgery</time_frame>
    <description>Difference in quality of life between baseline and 1 year measured using QLQ-CR29</description>
  </other_outcome>
  <other_outcome>
    <measure>Quality of life (LARS)</measure>
    <time_frame>At randomization and at one year from surgery</time_frame>
    <description>Difference in quality of life between baseline and 1 year measured using LARS</description>
  </other_outcome>
  <other_outcome>
    <measure>Adverse effects of antibiotics</measure>
    <time_frame>Within 30 days from surgery</time_frame>
    <description>Adverse effects of antibiotics</description>
  </other_outcome>
  <other_outcome>
    <measure>Bowel microbiota</measure>
    <time_frame>Before, at, 6 months, and 1 year after surgery.</time_frame>
    <description>Bowel microbiota</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">604</enrollment>
  <condition>Rectal Adenocarcinoma</condition>
  <condition>Rectum Neoplasm</condition>
  <condition>Rectum Carcinoma</condition>
  <condition>Colorectal Cancer</condition>
  <condition>Colorectal Neoplasms</condition>
  <condition>Colorectal Carcinoma</condition>
  <condition>Surgical Site Infection</condition>
  <condition>Surgery--Complications</condition>
  <arm_group>
    <arm_group_label>Mechanical Bowel Preparation and Oral Antibiotics</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mechanical Bowel Preparation and Oral Antibiotics</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mechanical Bowel Preparation Only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Mechanical Bowel Preparation Only</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oral Antibiotics</intervention_name>
    <description>Oral antibiotics (neomycin 1g and metronidazole 1g at 3pm and 11pm the day before surgery)</description>
    <arm_group_label>Mechanical Bowel Preparation and Oral Antibiotics</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Oral placebos (placebo 1 and placebo 2 at 3pm and 11pm the day before surgery)</description>
    <arm_group_label>Mechanical Bowel Preparation Only</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mechanical Bowel Preparation</intervention_name>
    <description>Mechanical Bowel Preparation using 2L polyethylene glycol (Moviprep)</description>
    <arm_group_label>Mechanical Bowel Preparation Only</arm_group_label>
    <arm_group_label>Mechanical Bowel Preparation and Oral Antibiotics</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for anterior rectal resection with primary anastomosis

        Exclusion Criteria:

          -  Emergency operation

          -  Bowel obstruction

          -  Existing stoma

          -  Other reason preventing mechanical bowel preparation

          -  Allergy to neomycin or metronidazole

          -  Age &lt; 18 years

          -  Lack of co-operation

        Exclusion criteria after randomization:

          -  Patient did not undergo surgery

          -  Anterior resection was not performed

          -  Colonic anastomosis was not performed
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laura Koskenvuo, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Helsinki University Central Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anna Lepistö, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Helsinki University Central Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ville Sallinen, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Helsinki University Central Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laura Koskenvuo, MD, PhD</last_name>
    <phone>+358-9-4711</phone>
    <email>laura.koskenvuo@hus.fi</email>
  </overall_contact>
  <location>
    <facility>
      <name>Helsinki University Hospital</name>
      <address>
        <city>Helsinki</city>
        <country>Finland</country>
      </address>
    </facility>
    <contact>
      <last_name>Laura Koskenvuo, MD, PhD</last_name>
      <email>laura.koskenvuo@hus.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <country>Finland</country>
      </address>
    </facility>
    <contact>
      <last_name>Marja Hyöty, MD</last_name>
      <email>marja.hyoty@pshp.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Turku University Hospital</name>
      <address>
        <city>Turku</city>
        <country>Finland</country>
      </address>
    </facility>
    <contact>
      <last_name>Pirita Varpe, MD</last_name>
      <email>pirita.varpe@tyks.fi</email>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>February 14, 2020</study_first_submitted>
  <study_first_submitted_qc>February 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 24, 2020</study_first_posted>
  <last_update_submitted>March 13, 2020</last_update_submitted>
  <last_update_submitted_qc>March 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Helsinki University Central Hospital</investigator_affiliation>
    <investigator_full_name>Ville Sallinen</investigator_full_name>
    <investigator_title>Adj. Prof.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Surgical Wound Infection</mesh_term>
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Adenocarcinoma</mesh_term>
    <mesh_term>Rectal Neoplasms</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

